EDGAR Filing Documents for 0001193125-17-254546

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001193125-17-254546

Filing Date

2017-08-10

Accepted

2017-08-10 16:36:06

Documents

Period of Report

2017-08-10

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	d435340d6k.htm	6-K	12379
2	EX-99.1	d435340dex991.htm	EX-99.1	335831
3	EX-99.2	d435340dex992.htm	EX-99.2	220909
4	EX-99.3	d435340dex993.htm	EX-99.3	10272
5	EX-99.4	d435340dex994.htm	EX-99.4	10275
6	GRAPHIC	g435340g0810090944658.jpg	GRAPHIC	2337
7	GRAPHIC	g435340g0810091714045.jpg	GRAPHIC	2337
	Complete submission text file	0001193125-17-254546.txt		597424

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8

Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272

Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)